1 Cancer Biomarkers Market Overview 1.1 Product Overview and Scope of Cancer Biomarkers 1.2 Cancer Biomarkers Segment by Type 1.2.1 Global Cancer Biomarkers Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Protein Biomarkers 1.2.3 Genetic Biomarkers 1.2.4 Others 1.3 Cancer Biomarkers Segment by Application 1.3.1 Cancer Biomarkers Sales Comparison by Application: 2020 VS 2026 1.3.2 Breast Cancer 1.3.3 Lung Cancer 1.3.4 Colorectal Cancer 1.3.5 Melanoma 1.3.6 Blood Cancer 1.3.7 Prostate Cancer 1.3.8 Ovarian Cancer 1.3.9 Stomach Cancer 1.3.10 Liver Cancer 1.4 Global Cancer Biomarkers Market Size Estimates and Forecasts 1.4.1 Global Cancer Biomarkers Revenue 2015-2026 1.4.2 Global Cancer Biomarkers Sales 2015-2026 1.4.3 Cancer Biomarkers Market Size by Region: 2020 Versus 2026 1.5 Cancer Biomarkers Industry 1.6 Cancer Biomarkers Market Trends 2 Global Cancer Biomarkers Market Competition by Manufacturers 2.1 Global Cancer Biomarkers Sales Market Share by Manufacturers (2015-2020) 2.2 Global Cancer Biomarkers Revenue Share by Manufacturers (2015-2020) 2.3 Global Cancer Biomarkers Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Cancer Biomarkers Manufacturing Sites, Area Served, Product Type 2.5 Cancer Biomarkers Market Competitive Situation and Trends 2.5.1 Cancer Biomarkers Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Cancer Biomarkers Players (Opinion Leaders) 3 Cancer Biomarkers Retrospective Market Scenario by Region 3.1 Global Cancer Biomarkers Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Cancer Biomarkers Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Cancer Biomarkers Market Facts & Figures by Country 3.3.1 North America Cancer Biomarkers Sales by Country 3.3.2 North America Cancer Biomarkers Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Cancer Biomarkers Market Facts & Figures by Country 3.4.1 Europe Cancer Biomarkers Sales by Country 3.4.2 Europe Cancer Biomarkers Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Cancer Biomarkers Market Facts & Figures by Region 3.5.1 Asia Pacific Cancer Biomarkers Sales by Region 3.5.2 Asia Pacific Cancer Biomarkers Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Cancer Biomarkers Market Facts & Figures by Country 3.6.1 Latin America Cancer Biomarkers Sales by Country 3.6.2 Latin America Cancer Biomarkers Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Cancer Biomarkers Market Facts & Figures by Country 3.7.1 Middle East and Africa Cancer Biomarkers Sales by Country 3.7.2 Middle East and Africa Cancer Biomarkers Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Cancer Biomarkers Historic Market Analysis by Type 4.1 Global Cancer Biomarkers Sales Market Share by Type (2015-2020) 4.2 Global Cancer Biomarkers Revenue Market Share by Type (2015-2020) 4.3 Global Cancer Biomarkers Price Market Share by Type (2015-2020) 4.4 Global Cancer Biomarkers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Cancer Biomarkers Historic Market Analysis by Application 5.1 Global Cancer Biomarkers Sales Market Share by Application (2015-2020) 5.2 Global Cancer Biomarkers Revenue Market Share by Application (2015-2020) 5.3 Global Cancer Biomarkers Price by Application (2015-2020) 6 Company Profiles and Key Figures in Cancer Biomarkers Business 6.1 Abbott Laboratories 6.1.1 Corporation Information 6.1.2 Abbott Laboratories Description, Business Overview and Total Revenue 6.1.3 Abbott Laboratories Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Abbott Laboratories Products Offered 6.1.5 Abbott Laboratories Recent Development 6.2 Thermo Fisher Scientific 6.2.1 Thermo Fisher Scientific Corporation Information 6.2.2 Thermo Fisher Scientific Description, Business Overview and Total Revenue 6.2.3 Thermo Fisher Scientific Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Thermo Fisher Scientific Products Offered 6.2.5 Thermo Fisher Scientific Recent Development 6.3 F. Hoffmann-La Roche Ltd 6.3.1 F. Hoffmann-La Roche Ltd Corporation Information 6.3.2 F. Hoffmann-La Roche Ltd Description, Business Overview and Total Revenue 6.3.3 F. Hoffmann-La Roche Ltd Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.3.4 F. Hoffmann-La Roche Ltd Products Offered 6.3.5 F. Hoffmann-La Roche Ltd Recent Development 6.4 Illumina,Inc. 6.4.1 Illumina,Inc. Corporation Information 6.4.2 Illumina,Inc. Description, Business Overview and Total Revenue 6.4.3 Illumina,Inc. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Illumina,Inc. Products Offered 6.4.5 Illumina,Inc. Recent Development 6.5 Agilent Technologies 6.5.1 Agilent Technologies Corporation Information 6.5.2 Agilent Technologies Description, Business Overview and Total Revenue 6.5.3 Agilent Technologies Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Agilent Technologies Products Offered 6.5.5 Agilent Technologies Recent Development 6.6 Qiagen NV 6.6.1 Qiagen NV Corporation Information 6.6.2 Qiagen NV Description, Business Overview and Total Revenue 6.6.3 Qiagen NV Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Qiagen NV Products Offered 6.6.5 Qiagen NV Recent Development 6.7 Merck & Co. 6.6.1 Merck & Co. Corporation Information 6.6.2 Merck & Co. Description, Business Overview and Total Revenue 6.6.3 Merck & Co. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Merck & Co. Products Offered 6.7.5 Merck & Co. Recent Development 6.8 Hologic,Inc. 6.8.1 Hologic,Inc. Corporation Information 6.8.2 Hologic,Inc. Description, Business Overview and Total Revenue 6.8.3 Hologic,Inc. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Hologic,Inc. Products Offered 6.8.5 Hologic,Inc. Recent Development 6.9 Novartis AG 6.9.1 Novartis AG Corporation Information 6.9.2 Novartis AG Description, Business Overview and Total Revenue 6.9.3 Novartis AG Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Novartis AG Products Offered 6.9.5 Novartis AG Recent Development 6.10 BioMerieux SA 6.10.1 BioMerieux SA Corporation Information 6.10.2 BioMerieux SA Description, Business Overview and Total Revenue 6.10.3 BioMerieux SA Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.10.4 BioMerieux SA Products Offered 6.10.5 BioMerieux SA Recent Development 6.11 Genomic Health 6.11.1 Genomic Health Corporation Information 6.11.2 Genomic Health Cancer Biomarkers Description, Business Overview and Total Revenue 6.11.3 Genomic Health Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Genomic Health Products Offered 6.11.5 Genomic Health Recent Development 6.12 Affymetrix 6.12.1 Affymetrix Corporation Information 6.12.2 Affymetrix Cancer Biomarkers Description, Business Overview and Total Revenue 6.12.3 Affymetrix Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Affymetrix Products Offered 6.12.5 Affymetrix Recent Development 6.13 Roche Diagnostics Ltd. 6.13.1 Roche Diagnostics Ltd. Corporation Information 6.13.2 Roche Diagnostics Ltd. Cancer Biomarkers Description, Business Overview and Total Revenue 6.13.3 Roche Diagnostics Ltd. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Roche Diagnostics Ltd. Products Offered 6.13.5 Roche Diagnostics Ltd. Recent Development 7 Cancer Biomarkers Manufacturing Cost Analysis 7.1 Cancer Biomarkers Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Cancer Biomarkers 7.4 Cancer Biomarkers Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Cancer Biomarkers Distributors List 8.3 Cancer Biomarkers Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Cancer Biomarkers Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Cancer Biomarkers by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Cancer Biomarkers by Type (2021-2026) 10.2 Cancer Biomarkers Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Cancer Biomarkers by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Cancer Biomarkers by Application (2021-2026) 10.3 Cancer Biomarkers Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Cancer Biomarkers by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Cancer Biomarkers by Region (2021-2026) 10.4 North America Cancer Biomarkers Estimates and Projections (2021-2026) 10.5 Europe Cancer Biomarkers Estimates and Projections (2021-2026) 10.6 Asia Pacific Cancer Biomarkers Estimates and Projections (2021-2026) 10.7 Latin America Cancer Biomarkers Estimates and Projections (2021-2026) 10.8 Middle East and Africa Cancer Biomarkers Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Cancer Biomarkers Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Cancer Biomarkers Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Cancer Biomarkers Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Cancer Biomarkers Manufacturers Covered in This Study Table 5. Global Cancer Biomarkers Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Cancer Biomarkers Sales Share by Manufacturers (2015-2020) Table 7. Global Cancer Biomarkers Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Cancer Biomarkers Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Cancer Biomarkers Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Cancer Biomarkers Sales Sites and Area Served Table 11. Manufacturers Cancer Biomarkers Product Types Table 12. Global Cancer Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Cancer Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biomarkers as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Cancer Biomarkers Players Table 16. Global Cancer Biomarkers Sales (K MT) by Region (2015-2020) Table 17. Global Cancer Biomarkers Sales Market Share by Region (2015-2020) Table 18. Global Cancer Biomarkers Revenue (Million US$) by Region (2015-2020) Table 19. Global Cancer Biomarkers Revenue Market Share by Region (2015-2020) Table 20. North America Cancer Biomarkers Sales by Country (2015-2020) (K MT) Table 21. North America Cancer Biomarkers Sales Market Share by Country (2015-2020) Table 22. North America Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million) Table 23. North America Cancer Biomarkers Revenue Market Share by Country (2015-2020) Table 24. Europe Cancer Biomarkers Sales by Country (2015-2020) (K MT) Table 25. Europe Cancer Biomarkers Sales Market Share by Country (2015-2020) Table 26. Europe Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Cancer Biomarkers Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Cancer Biomarkers Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Cancer Biomarkers Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Cancer Biomarkers Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Cancer Biomarkers Revenue Market Share by Region (2015-2020) Table 32. Latin America Cancer Biomarkers Sales by Country (2015-2020) (K MT) Table 33. Latin America Cancer Biomarkers Sales Market Share by Country (2015-2020) Table 34. Latin America Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Cancer Biomarkers Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Cancer Biomarkers Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Cancer Biomarkers Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Cancer Biomarkers Revenue Market Share by Country (2015-2020) Table 40. Global Cancer Biomarkers Sales (K MT) by Type (2015-2020) Table 41. Global Cancer Biomarkers Sales Share by Type (2015-2020) Table 42. Global Cancer Biomarkers Revenue (Million US$) by Type (2015-2020) Table 43. Global Cancer Biomarkers Revenue Share by Type (2015-2020) Table 44. Global Cancer Biomarkers Price (USD/MT) by Type (2015-2020) Table 45. Global Cancer Biomarkers Sales (K MT) by Application (2015-2020) Table 46. Global Cancer Biomarkers Sales Market Share by Application (2015-2020) Table 47. Global Cancer Biomarkers Sales Growth Rate by Application (2015-2020) Table 48. Abbott Laboratories Cancer Biomarkers Corporation Information Table 49. Abbott Laboratories Description and Business Overview Table 50. Abbott Laboratories Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Abbott Laboratories Main Product Table 52. Abbott Laboratories Recent Development Table 53. Thermo Fisher Scientific Cancer Biomarkers Corporation Information Table 54. Thermo Fisher Scientific Corporation Information Table 55. Thermo Fisher Scientific Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Thermo Fisher Scientific Main Product Table 57. Thermo Fisher Scientific Recent Development Table 58. F. Hoffmann-La Roche Ltd Cancer Biomarkers Corporation Information Table 59. F. Hoffmann-La Roche Ltd Corporation Information Table 60. F. Hoffmann-La Roche Ltd Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. F. Hoffmann-La Roche Ltd Main Product Table 62. F. Hoffmann-La Roche Ltd Recent Development Table 63. Illumina,Inc. Cancer Biomarkers Corporation Information Table 64. Illumina,Inc. Corporation Information Table 65. Illumina,Inc. Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Illumina,Inc. Main Product Table 67. Illumina,Inc. Recent Development Table 68. Agilent Technologies Cancer Biomarkers Corporation Information Table 69. Agilent Technologies Corporation Information Table 70. Agilent Technologies Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Agilent Technologies Main Product Table 72. Agilent Technologies Recent Development Table 73. Qiagen NV Cancer Biomarkers Corporation Information Table 74. Qiagen NV Corporation Information Table 75. Qiagen NV Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Qiagen NV Main Product Table 77. Qiagen NV Recent Development Table 78. Merck & Co. Cancer Biomarkers Corporation Information Table 79. Merck & Co. Corporation Information Table 80. Merck & Co. Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Merck & Co. Main Product Table 82. Merck & Co. Recent Development Table 83. Hologic,Inc. Cancer Biomarkers Corporation Information Table 84. Hologic,Inc. Corporation Information Table 85. Hologic,Inc. Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Hologic,Inc. Main Product Table 87. Hologic,Inc. Recent Development Table 88. Novartis AG Cancer Biomarkers Corporation Information Table 89. Novartis AG Corporation Information Table 90. Novartis AG Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Novartis AG Main Product Table 92. Novartis AG Recent Development Table 93. BioMerieux SA Cancer Biomarkers Corporation Information Table 94. BioMerieux SA Corporation Information Table 95. BioMerieux SA Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. BioMerieux SA Main Product Table 97. BioMerieux SA Recent Development Table 98. Genomic Health Cancer Biomarkers Corporation Information Table 99. Genomic Health Corporation Information Table 100. Genomic Health Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 101. Genomic Health Main Product Table 102. Genomic Health Recent Development Table 103. Affymetrix Cancer Biomarkers Corporation Information Table 104. Affymetrix Corporation Information Table 105. Affymetrix Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 106. Affymetrix Main Product Table 107. Affymetrix Recent Development Table 108. Roche Diagnostics Ltd. Cancer Biomarkers Corporation Information Table 109. Roche Diagnostics Ltd. Corporation Information Table 110. Roche Diagnostics Ltd. Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 111. Roche Diagnostics Ltd. Main Product Table 112. Roche Diagnostics Ltd. Recent Development Table 113. Sales Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Cancer Biomarkers Distributors List Table 116. Cancer Biomarkers Customers List Table 117. Market Key Trends Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 119. Key Challenges Table 120. Global Cancer Biomarkers Sales (K MT) Forecast by Type (2021-2026) Table 121. Global Cancer Biomarkers Sales Market Share Forecast by Type (2021-2026) Table 122. Global Cancer Biomarkers Revenue (Million US$) Forecast by Type (2021-2026) Table 123. Global Cancer Biomarkers Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 124. Global Cancer Biomarkers Sales (K MT) Forecast by Application (2021-2026) Table 125. Global Cancer Biomarkers Revenue (Million US$) Forecast by Application (2021-2026) Table 126. Global Cancer Biomarkers Sales (K MT) Forecast by Region (2021-2026) Table 127. Global Cancer Biomarkers Sales Market Share Forecast by Region (2021-2026) Table 128. Global Cancer Biomarkers Revenue Forecast by Region (2021-2026) (US$ Million) Table 129. Global Cancer Biomarkers Revenue Market Share Forecast by Region (2021-2026) Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Cancer Biomarkers Figure 2. Global Cancer Biomarkers Sales Market Share by Type: 2020 VS 2026 Figure 3. Protein Biomarkers Product Picture Figure 4. Genetic Biomarkers Product Picture Figure 5. Others Product Picture Figure 6. Global Cancer Biomarkers Consumption Market Share by Application: 2020 VS 2026 Figure 7. Breast Cancer Figure 8. Lung Cancer Figure 9. Colorectal Cancer Figure 10. Melanoma Figure 11. Blood Cancer Figure 12. Prostate Cancer Figure 13. Ovarian Cancer Figure 14. Stomach Cancer Figure 15. Liver Cancer Figure 16. Global Cancer Biomarkers Market Size 2015-2026 (US$ Million) Figure 17. Global Cancer Biomarkers Sales Capacity (K MT) (2015-2026) Figure 18. Global Cancer Biomarkers Market Size Market Share by Region: 2020 Versus 2026 Figure 19. Cancer Biomarkers Sales Share by Manufacturers in 2020 Figure 20. Global Cancer Biomarkers Revenue Share by Manufacturers in 2019 Figure 21. The Global 5 and 10 Largest Players: Market Share by Cancer Biomarkers Revenue in 2019 Figure 22. Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 23. Global Cancer Biomarkers Sales Market Share by Region (2015-2020) Figure 24. Global Cancer Biomarkers Sales Market Share by Region in 2019 Figure 25. Global Cancer Biomarkers Revenue Market Share by Region (2015-2020) Figure 26. Global Cancer Biomarkers Revenue Market Share by Region in 2019 Figure 27. North America Cancer Biomarkers Sales Market Share by Country in 2019 Figure 28. North America Cancer Biomarkers Revenue Market Share by Country in 2019 Figure 29. U.S. Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 30. U.S. Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. Canada Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 32. Canada Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Europe Cancer Biomarkers Sales Market Share by Country in 2019 Figure 34. Europe Cancer Biomarkers Revenue Market Share by Country in 2019 Figure 35. Germany Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 36. Germany Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. France Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 38. France Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. U.K. Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 40. U.K. Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Italy Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 42. Italy Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Russia Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 44. Russia Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Asia Pacific Cancer Biomarkers Sales Market Share by Region in 2019 Figure 46. Asia Pacific Cancer Biomarkers Revenue Market Share by Region in 2019 Figure 47. China Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 48. China Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Japan Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 50. Japan Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. South Korea Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 52. South Korea Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. India Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 54. India Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Australia Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 56. Australia Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Taiwan Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 58. Taiwan Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Indonesia Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 60. Indonesia Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Thailand Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 62. Thailand Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Malaysia Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 64. Malaysia Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Philippines Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 66. Philippines Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Vietnam Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 68. Vietnam Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Latin America Cancer Biomarkers Sales Market Share by Country in 2019 Figure 70. Latin America Cancer Biomarkers Revenue Market Share by Country in 2019 Figure 71. Mexico Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 72. Mexico Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Brazil Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 74. Brazil Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Argentina Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 76. Argentina Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Middle East and Africa Cancer Biomarkers Sales Market Share by Country in 2019 Figure 78. Middle East and Africa Cancer Biomarkers Revenue Market Share by Country in 2019 Figure 79. Turkey Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 80. Turkey Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Saudi Arabia Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 82. Saudi Arabia Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. U.A.E Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT) Figure 84. U.A.E Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Sales Market Share of Cancer Biomarkers by Type (2015-2020) Figure 86. Sales Market Share of Cancer Biomarkers by Type in 2019 Figure 87. Revenue Share of Cancer Biomarkers by Type (2015-2020) Figure 88. Revenue Market Share of Cancer Biomarkers by Type in 2019 Figure 89. Global Cancer Biomarkers Sales Growth by Type (2015-2020) (K MT) Figure 90. Global Cancer Biomarkers Sales Market Share by Application (2015-2020) Figure 91. Global Cancer Biomarkers Sales Market Share by Application in 2019 Figure 92. Global Revenue Share of Cancer Biomarkers by Application (2015-2020) Figure 93. Global Revenue Share of Cancer Biomarkers by Application in 2020 Figure 94. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Illumina,Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Qiagen NV Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Hologic,Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. BioMerieux SA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. Affymetrix Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. Roche Diagnostics Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. Price Trend of Key Raw Materials Figure 108. Manufacturing Cost Structure of Cancer Biomarkers Figure 109. Manufacturing Process Analysis of Cancer Biomarkers Figure 110. Cancer Biomarkers Industrial Chain Analysis Figure 111. Channels of Distribution Figure 112. Distributors Profiles Figure 113. Porter's Five Forces Analysis Figure 114. North America Cancer Biomarkers Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 115. North America Cancer Biomarkers Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Europe Cancer Biomarkers Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 117. Europe Cancer Biomarkers Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Latin America Cancer Biomarkers Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 119. Latin America Cancer Biomarkers Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Middle East and Africa Cancer Biomarkers Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 121. Middle East and Africa Cancer Biomarkers Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Asia Pacific Cancer Biomarkers Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 123. Asia Pacific Cancer Biomarkers Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 124. Bottom-up and Top-down Approaches for This Report Figure 125. Data Triangulation Figure 126. Key Executives Interviewed

Abbott Laboratories Thermo Fisher Scientific F. Hoffmann-La Roche Ltd Illumina,Inc. Agilent Technologies Qiagen NV Merck & Co. Hologic,Inc. Novartis AG BioMerieux SA Genomic Health Affymetrix Roche Diagnostics Ltd.